EUCTR2005-001005-26-ES进行中（未招募）不适用
A single-arm phase II study of dose-dense gemcitabine and carboplatin as neoadyuvant chemotherapy, with pegfilgrastim support for subjects with operable stage IIIA NSCLC
Spanish Lung Cancer Group0 个研究点开始时间: 2006年5月17日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Subjects with Stage IIIA NSCLC (any subtype), confirmed by histological or cytological diagnosis
- •- Clinically measurable lesions amenable to curative surgical resection
- •- No prior tumoral therapy
- •- Men or women between 18 and 65 years old
- •- ECOG status of 0-1
- •- Adequate baseline hematology and adequate liver and renal function
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Subjects with Stage I-II and Stage IIIB-IV disease
- •- Concurrent administration of any other tumoral therapy, including radiotherapy, cytotoxic chemotherapy, inmunotherapy, molecualr target therapy
- •- Treatment with a investigator drug in the last 30 days before the inclusion period
- •- Non-controlled diabetes mellitus
- •- Previous significant neurological or mental disorder, such a epilepsy or madness
- •- Another primary maligny neoplasie detected during the inclusion period
研究者
相似试验
进行中（未招募）
1 期
Study of Gemcitabine-Carboplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancerocally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-002041-31-ITELI LILLY & COMPANY, LILLY CORPORATE CENTER50
进行中（未招募）
1 期
Study of Gemcitabine-Carboplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancerocally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 19.0Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-002041-31-BEEli Lilly and Company50
进行中（未招募）
1 期
A Phase 2 Single-Arm Study of Gemcitabine in Combination with Oxaliplatin in Pediatric Patients with Relapsed or Refractory Neuroblastoma or Miscellaneous Solid Non-CNS Tumors - N/AEUCTR2005-005219-36-GBEli Lilly and Company Limited70
进行中（未招募）
不适用
A Phase 2 Single-Arm Study of Gemcitabine in Combination with Oxaliplatin in Pediatric Patients with Relapsed or Refractory Neuroblastoma or Miscellaneous Solid Non-CNS TumorsEUCTR2005-005219-36-DEEli Lilly and Company Limited70
已完成
2 期
Single-arm phase II study of induction Gemcitabine+nab-paclitaxel followed by gemcitabine and concurrent radiotherapy for locally advanced pancreatic cancerocally advanced pancreatic cancerJPRN-UMIN000027756Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute40